OncoLink

Print
 

Low dose bleomycin every three weeks with cisplatin and etoposide results in excellent event free survival and survival in children and adolescents with gonadal malignant germ cell tumors (MGCT) A POG/CCG Study

Presenter: T.A. Olson
Presenter's Affiliation: Children's Oncology Group
Type of Session: Scientific

BackgroundMaterials and MethodsResultsAuthor's ConclusionsClinical/Scientific Implications

Oncolink's ASCO Coverage made possible by an unrestricted Educational Grant from Bristol-Myers Squibb Oncology.


OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.


Information Provided By: www.oncolink.org | © 2017 Trustees of The University of Pennsylvania